Sleep-related eating disorder after dose escalation of sodium oxybate in narcolepsy type 1. [PDF]
Al Mazyad RA +3 more
europepmc +1 more source
Guidelines for daily sodium intake: a counterpoint to the current recommendation for low sodium intake. [PDF]
Mente A.
europepmc +1 more source
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders. [PDF]
Aribindi K, Shende TC, Albertson TE.
europepmc +1 more source
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience. [PDF]
Kushida CA.
europepmc +1 more source
Reply to "Unexpectedly higher mortality in non‑type 1 narcolepsy: diagnostic heterogeneity or unmeasured confounders?" [PDF]
Sharafkhaneh A +8 more
europepmc +1 more source
Narcolepsy with co-occurring epilepsy: diagnostic pitfalls and management strategy. [PDF]
Zhang X +7 more
europepmc +1 more source
Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine. [PDF]
Arias-Carrión O +3 more
europepmc +1 more source
Rapid Eye Movement (REM)-Predominant Obstructive Sleep Apnea (OSA) Coexisting With and Initially Obscuring Narcolepsy Type 1: A Nine-Year Longitudinal Case Report. [PDF]
Bouhamdi A +11 more
europepmc +1 more source
Clinical pearls for the treatment of narcolepsy. [PDF]
Bulloch MN, Geyer JD.
europepmc +1 more source

